TINAVI(SH:688277) Xin Lang Cai Jing·2026-02-05 03:17Group 1 - Tianzhihang Medical Technology Co., Ltd. experienced a stock price increase of 5.17%, reaching 25.23 CNY per share, with a trading volume of 305 million CNY and a turnover rate of 2.72%, resulting in a total market capitalization of 11.505 billion CNY [1] - The company, established on October 22, 2010, and listed on July 7, 2020, focuses on the research, production, sales, and service of orthopedic surgical navigation robots. The revenue composition is as follows: orthopedic surgical navigation robots 58.31%, supporting equipment and consumables 23.86%, technical services 16.49%, and others 1.31% [1] Group 2 - Among the top ten circulating shareholders of Tianzhihang, Huaxia Fund's Huaxia CSI Robot ETF (562500) increased its holdings by 1.6284 million shares in the third quarter, holding a total of 8.7238 million shares, which accounts for 1.93% of the circulating shares. The estimated floating profit today is approximately 10.8175 million CNY [2] - The Huaxia CSI Robot ETF (562500) was established on December 17, 2021, with a latest scale of 26.465 billion CNY. Year-to-date returns are 4.34%, ranking 2777 out of 5566 in its category; the one-year return is 30.24%, ranking 2430 out of 4285; and since inception, the return is 6.23% [2] Group 3 - The fund manager of Huaxia CSI Robot ETF (562500) is Hualong. As of the report date, Hualong has served for 3 years and 169 days, with total fund assets of 39.451 billion CNY. The best fund return during the tenure is 209.94%, while the worst return is -15.08% [3]